Evaluation of pain scores during intravitreal injection in systemic conditions and in conjunction with medications.

Background: Intravitreal injection (IVI) is a common practice in today's ophthalmology clinics. The pain that patients will experience after the application may be important in compliance with the treatment. Objectives: This study aimed to investigate the correlation between various clinical charact...

Descripción completa

Detalles Bibliográficos
Publicado en:Therapeutic Advances in Ophthalmology Vol. 17; pp. 1 - 10
Autores principales: Sezer, Taha, Altıkardeşler, Emir, Erdoğan, Kübra, Arslan, Betül, Çolak, Kübra
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. 8/24/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190387443&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190387443
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        25158414
        LAW0
      jtl: Therapeutic Advances in Ophthalmology
      issn: 25158414
      maglogo: Y
    pubinfo:
      dt: 8/24/2025
      vid: 17
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        190387443
        190387443
        190387443
        10.1177/25158414241275360
        190387443
      ppf: 1
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Evaluation of pain scores during intravitreal injection in systemic conditions and in conjunction with medications.
      aug:
        au:
          Sezer, Taha
          Altıkardeşler, Emir
          Erdoğan, Kübra
          Arslan, Betül
          Çolak, Kübra
        affil: Conceptualization, Department of Ophthalmology, Duzce University School of Medicine, Duzce 81620, Turkey
      sug:
        subj:
          Pain Evaluation
          Injections, Intravitreal
          Disease Attributes
          Visual Analog Scaling Evaluation
          Eye Diseases Drug Therapy
          Drug Utilization
          Human
          Male
          Female
          Prospective Studies
          Middle Age
          Aged
          Data Analysis Software
          Descriptive Statistics
          T-Tests
          Mann-Whitney U Test
          Spearman's Rank Correlation Coefficient
          Regression
          Effect Size
          Headache
          Analgesics, Opioid Administration and Dosage
          Syncope, Vasovagal
          Antidepressive Agents
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background: Intravitreal injection (IVI) is a common practice in today's ophthalmology clinics. The pain that patients will experience after the application may be important in compliance with the treatment. Objectives: This study aimed to investigate the correlation between various clinical characteristics of patients receiving IVI and corresponding visual analogue scale (VAS) scores (0: no pain to 10: severe pain). Design: Single-centre, Prospective study. Methods: A total of 313 participants (168 females, 145 males) with a mean age of 66.91 ± 9.67 years underwent IVI for diabetic retinopathy (DRP), retinal vein occlusion (RVO), or age-related macular degeneration (AMD). Eye examinations, including visual acuity and intraocular pressure measurements, were also conducted, and injection indications were determined based on dilated fundus examinations and spectral domain optical coherence tomography images. Following the injections, the researchers solicited VAS scores ranging from 0 to 10 (no pain to severe pain). The study explored the relationships between clinical characteristics, headache frequency, joint and muscle pain, analgesic use, surgical history, antidepressant use, vasovagal syncope, previous injections, and VAS score. Results: The mean VAS score was 4.77 ± 2.90. While DRP and RVO had similar VAS scores (4.95 ± 2.98 and 5.22 ± 2.70, respectively), the AMD group had significantly lower scores (4.09 ± 2.64). Compared with nonusers, antidepressant users had significantly greater VAS scores (5.79 ± 3.43) (4.52 ± 2.70) (p < 0.05). Patients with a history of syncope had significantly greater VAS scores (p < 0.05). In patients reporting monthly headaches, a positive correlation was found between headache frequency and VAS score (r = 0.23, p < 0.01). Conclusion: For individuals experiencing daily headaches, inquiries about vasovagal syncope and antidepressant use may be beneficial, considering the potential association of these symptoms with higher VAS scores after IVIs.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N